文 献haemangioma. Lancet 2017; 390(10089): 85-94.9）Cochrane NJ, Walker GD, Manton DJ, Reynolds EC. Comparison of quantitative light-induced fluorescence, digital photography and transverse microradiography for quantification of enamel remineralization. Aust Dent J 2012; 57(3): 271-6.10）Wang S, Cathro P, Heithersay G, Briggs N, Ratnayake J, Zilm P. A colourimetric evaluation of the effect of bacterial contamination on teeth stained with blood in vitro: Evaluation of the efficacy of two different bleaching regimes. Aust Dent J 2018; 63(2): 253-60.11）Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplantation 2013; 48: 452-8.12）Takechi T, Kumokawa T, Kato R, Higuchi T, Kaneko T, Ieiri I. Population pharmacokinetics and pharmacodynamics of oral propranolol in pediatric patients with infantile hemangioma. J Clin Pharmacol 2018; 58(10): 1361-70.13）Chan H, McKay C, Adams S, Wargon O. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics 2013; 131: e1739-47.14）Padula C, Nicoli S, Pescina S, Santi P. The Influence of Formulation and excipients on propranolol Skin Permeation and Retention. BioMed Res Int 2018; 1281673.15）McMahon P, Oza V, Frieden IJ. Topical timolol for infantile hemangiomas: Putting a note of caution in “cautiously optimistic”. Pediatr Dermatol 2012; 29(1): 127-30.401）Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile 2）Tiemann L, Hein S. Infantile hemangioma: A review of current pharmacotherapy treatment and practice pearls. J Pediatr Pharmacol Ther 2020; 25(7): 586-99.3）Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am 2014; 61(2): 383-402.4）Zweegers J, van der Vleuten CJM. The psychosocial impact of an infantile haemangioma on children and their parents. Arch Dis Child 2012; 97(10): 922-6.5）Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358(24): 2649-51.6）Kaneko T, Sasaki S, Baba N, Koh K, Matsui K, Ohjimi H, et al. Efficacy and safety of oral propranolol for infantile hemangioma in Japan. Pediatr Int 2017; 59(8): 869-77.7）Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015; 372(8): 735-46.8）Price A, Rai S, Mcleod RWJ, Birchall JC, Elhassan HA. Topical propranolol for infantile haemangiomas: A systematic review. J Eur Acad Dermatol Venereol 2018; 32(12): 2083-9.
元のページ ../index.html#54